受强制性开放获取政策约束的文章 - Ahmad Y Abuhelwa了解详情
无法在其他位置公开访问的文章：1 篇
Enhanced bellmunt risk score for survival prediction in urothelial carcinoma treated with immunotherapy
AY Abuhelwa, J Bellmunt, G Kichenadasse, RA McKinnon, A Rowland, ...
Clinical Genitourinary Cancer 20 (2), 132-138, 2022
强制性开放获取政策： National Health and Medical Research Council, Australia
可在其他位置公开访问的文章：10 篇
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy
S Badaoui, A Shahnam, RA McKinnon, AY Abuhelwa, MJ Sorich, ...
Translational Lung Cancer Research 11 (3), 432, 2022
强制性开放获取政策： National Health and Medical Research Council, Australia
Audit of data sharing by pharmaceutical companies for anticancer medicines approved by the US Food and Drug Administration
ND Modi, AY Abuhelwa, RA McKinnon, AV Boddy, M Haseloff, MD Wiese, ...
JAMA oncology 8 (9), 1310-1316, 2022
强制性开放获取政策： National Health and Medical Research Council, Australia
Prediction of severe neutropenia and diarrhoea in breast cancer patients treated with abemaciclib
ND Modi, AY Abuhelwa, S Badaoui, E Shaw, K Shankaran, RA McKinnon, ...
The Breast 58, 57-62, 2021
强制性开放获取政策： National Health and Medical Research Council, Australia
Heterogeneity and utility of pharmaceutical company sharing of individual-participant data packages
AM Hopkins, ND Modi, AY Abuhelwa, G Kichenadasse, NM Kuderer, ...
JAMA oncology 9 (12), 1621-1626, 2023
强制性开放获取政策： National Health and Medical Research Council, Australia
Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer
ND Modi, NO Danell, RNA Perry, AY Abuhelwa, A Rathod, S Badaoui, ...
ESMO open 7 (3), 100475, 2022
强制性开放获取政策： National Health and Medical Research Council, Australia
Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma: pooled analysis of three clinical trials
SA Almansour, MAY Alqudah, Z Abuhelwa, HO Al-Shamsi, MH Semreen, ...
Scientific Reports 14 (1), 591, 2024
强制性开放获取政策： National Health and Medical Research Council, Australia
Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling Approach
MJ Sorich, AT Manning-Bennett, LX Li, A Shahnam, G Kichenadasse, ...
Targeted Oncology, 1-9, 2025
强制性开放获取政策： National Health and Medical Research Council, Australia
The state of individual participant data sharing for the highest-revenue medicines
ND Modi, LX Li, JM Logan, MD Wiese, AY Abuhelwa, RA McKinnon, ...
Clinical Trials, 17407745241286147, 2024
强制性开放获取政策： National Health and Medical Research Council, Australia
Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials
SA Almansour, MAY Alqudah, Z Abuhelwa, HO Al-Shamsi, A Alhuraiji, ...
Therapeutic Advances in Medical Oncology 16, 17588359241275387, 2024
强制性开放获取政策： National Health and Medical Research Council, Australia
Commentary: Association Between Antihypertensive Medication Use and Breast Cancer: A Systematic Review and Meta-Analysis
ND Modi, AY Abuhelwa, BD Menz, RA McKinnon, MJ Sorich, AM Hopkins
Frontiers in Pharmacology 12, 732622, 2021
强制性开放获取政策： National Health and Medical Research Council, Australia
出版信息和资助信息由计算机程序自动确定